دورية أكاديمية
Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation (DELINEATE-MR).
| العنوان: | Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation (DELINEATE-MR). |
|---|---|
| المؤلفون: | Long A; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.).; Departments of Biomedical Informatics (A.L., C.M.H., P.E.), Columbia University, New York, NY., Haggerty CM; Departments of Biomedical Informatics (A.L., C.M.H., P.E.), Columbia University, New York, NY.; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Finer J; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Hartzel D; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Jing L; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Keivani A; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Kelsey C; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Rocha D; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Ruhl J; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., vanMaanen D; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Metser G; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Duffy E; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Mawson T; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Maurer M; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Einstein AJ; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.).; Radiology (A.J.E.), Columbia University, New York, NY., Beecy A; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY (A.B., D.K.)., Kumaraiah D; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.).; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY (A.B., D.K.)., Homma S; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Liu Q; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Agarwal V; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Lebehn M; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Leon M; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.).; Cardiovascular Research Foundation, New York, NY (M. Leon)., Hahn R; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.)., Elias P; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.).; Departments of Biomedical Informatics (A.L., C.M.H., P.E.), Columbia University, New York, NY.; Information Technology Data Science, New York-Presbyterian Hospital, NY (C.M.H., J.F., D.H., L.J., A.K., C.K., D.R., J.R., D.v.M., P.E.)., Poterucha TJ; Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.). |
| المصدر: | Circulation [Circulation] 2024 Sep 17; Vol. 150 (12), pp. 911-922. Date of Electronic Publication: 2024 Jun 17. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Hagerstown, MD : Lippincott Williams & Wilkins Original Publication: [Dallas, Tex., etc., American Heart Association, etc.] |
| مواضيع طبية MeSH: | Mitral Valve Insufficiency*/diagnostic imaging , Mitral Valve Insufficiency*/physiopathology , Mitral Valve Insufficiency*/classification , Deep Learning*, Humans ; Male ; Female ; Aged ; Middle Aged ; Echocardiography/methods ; Severity of Illness Index ; Mitral Valve/diagnostic imaging ; ROC Curve |
| مستخلص: | Background: Artificial intelligence, particularly deep learning (DL), has immense potential to improve the interpretation of transthoracic echocardiography (TTE). Mitral regurgitation (MR) is the most common valvular heart disease and presents unique challenges for DL, including the integration of multiple video-level assessments into a final study-level classification. Methods: A novel DL system was developed to intake complete TTEs, identify color MR Doppler videos, and determine MR severity on a 4-step ordinal scale (none/trace, mild, moderate, and severe) using the reading cardiologist as a reference standard. This DL system was tested in internal and external test sets with performance assessed by agreement with the reading cardiologist, weighted κ, and area under the receiver-operating characteristic curve for binary classification of both moderate or greater and severe MR. In addition to the primary 4-step model, a 6-step MR assessment model was studied with the addition of the intermediate MR classes of mild-moderate and moderate-severe with performance assessed by both exact agreement and ±1 step agreement with the clinical MR interpretation. Results: A total of 61 689 TTEs were split into train (n=43 811), validation (n=8891), and internal test (n=8987) sets with an additional external test set of 8208 TTEs. The model had high performance in MR classification in internal (exact accuracy, 82%; κ=0.84; area under the receiver-operating characteristic curve, 0.98 for moderate or greater MR) and external test sets (exact accuracy, 79%; κ=0.80; area under the receiver-operating characteristic curve, 0.98 for moderate or greater MR). Most (63% internal and 66% external) misclassification disagreements were between none/trace and mild MR. MR classification accuracy was slightly higher using multiple TTE views (accuracy, 82%) than with only apical 4-chamber views (accuracy, 80%). In subset analyses, the model was accurate in the classification of both primary and secondary MR with slightly lower performance in cases of eccentric MR. In the analysis of the 6-step classification system, the exact accuracy was 80% and 76% with a ±1 step agreement of 99% and 98% in the internal and external test set, respectively. Conclusions: This end-to-end DL system can intake entire echocardiogram studies to accurately classify MR severity and may be useful in helping clinicians refine MR assessments. Competing Interests: Dr Poterucha owns stock in Abbott Laboratories and Baxter International with research support provided to his institution from the Amyloidosis Foundation, American Heart Association (awards 933452 and 23SCISA1077494; https://doi.org/10.58275/AHA.23SCISA1077494.pc.gr.172160), Eidos Therapeutics, Pfizer, Edwards Lifesciences, and Janssen. Dr Hahn reports speaker fees from Abbott Structural, Baylis Medical, Edwards Lifesciences, Medtronic, Philips Healthcare, and Siemens Healthineers; she has institutional consulting contracts for which she receives no direct compensation with Abbott Structural, Anteris, Edwards Lifesciences, Medtronic and Novartis; she is chief scientific officer for the Echocardiography Core Laboratory at the Cardiovascular Research Foundation for multiple industry-sponsored valve trials, for which she receives no direct industry compensation. Dr Einstein reports receiving authorship fees from Wolters Kluwer Healthcare—UpToDate and serving on a scientific advisory board for Canon Medical Systems; his institution has grants/grants pending from Attralus, BridgeBio, Canon Medical Systems, GE HealthCare, Intellia Therapeutics, Ionis Pharmaceuticals, Neovasc, Pfizer, Roche Medical Systems, and W.L. Gore & Associates. The other authors report no conflicts. |
| التعليقات: | Comment in: Circulation. 2024 Sep 17;150(12):934-937. doi: 10.1161/CIRCULATIONAHA.124.070954. (PMID: 39283937) |
| References: | Nat Biomed Eng. 2021 Jun;5(6):546-554. (PMID: 33558735) Mayo Clin Proc. 2020 Dec;95(12):2633-2643. (PMID: 33276836) JACC Cardiovasc Imaging. 2010 Mar;3(3):235-43. (PMID: 20223419) Lancet. 2018 Mar 10;391(10124):960-969. (PMID: 29536860) JACC Cardiovasc Imaging. 2018 Apr;11(4):628-643. (PMID: 29622181) Nature. 2023 Apr;616(7957):520-524. (PMID: 37020027) JACC Cardiovasc Imaging. 2021 Nov;14(11):2260-2262. (PMID: 34274282) Nature. 2020 Apr;580(7802):252-256. (PMID: 32269341) J Am Soc Echocardiogr. 2017 Apr;30(4):303-371. (PMID: 28314623) Arch Cardiovasc Dis. 2020 Oct;113(10):599-606. (PMID: 32994143) Biochem Med (Zagreb). 2012;22(3):276-82. (PMID: 23092060) JAMA Cardiol. 2022 Apr 01;7(4):386-395. (PMID: 35195663) Nat Rev Cardiol. 2021 Dec;18(12):853-864. (PMID: 34172950) J Am Soc Echocardiogr. 2003 Jul;16(7):777-802. (PMID: 12835667) JACC Cardiovasc Imaging. 2021 Apr;14(4):843-853. (PMID: 33454273) Circulation. 2021 Feb 2;143(5):e72-e227. (PMID: 33332150) Eur Heart J. 2016 Dec 14;37(47):3515-3522. (PMID: 27354049) Eur J Echocardiogr. 2008 Mar;9(2):250-4. (PMID: 17475569) J Am Coll Cardiol. 2019 Mar 26;73(11):1317-1335. (PMID: 30898208) Circulation. 2018 Oct 16;138(16):1623-1635. (PMID: 30354459) JACC Cardiovasc Imaging. 2021 Oct;14(10):1918-1928. (PMID: 34147442) J Am Coll Cardiol. 2023 Nov 14;82(20):1936-1948. (PMID: 37940231) Psychol Bull. 1968 Oct;70(4):213-20. (PMID: 19673146) Rev Port Cardiol. 2011 Jan;30(1):25-33. (PMID: 21425741) J Am Soc Echocardiogr. 2023 Jul;36(7):769-777. (PMID: 36958708) Circulation. 2012 Oct 16;126(16):2005-17. (PMID: 23071176) Eur Heart J. 2023 Nov 14;44(43):4592-4604. (PMID: 37611002) Lancet. 2006 Sep 16;368(9540):1005-11. (PMID: 16980116) |
| معلومات مُعتمدة: | 23SCISA1077494 United States AHA American Heart Association-American Stroke Association; 933452 United States AHA American Heart Association-American Stroke Association |
| فهرسة مساهمة: | Keywords: artificial intelligence; deep learning; echocardiography; mitral valve insufficiency |
| تواريخ الأحداث: | Date Created: 20240617 Date Completed: 20240916 Latest Revision: 20240919 |
| رمز التحديث: | 20240919 |
| مُعرف محوري في PubMed: | PMC11404755 |
| DOI: | 10.1161/CIRCULATIONAHA.124.068996 |
| PMID: | 38881496 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1524-4539 |
|---|---|
| DOI: | 10.1161/CIRCULATIONAHA.124.068996 |